Reuters logo
13 天前
BRIEF-Nektar Therapeutics Q2 loss per share $0.39
2017年8月8日 / 晚上9点23分 / 13 天前

BRIEF-Nektar Therapeutics Q2 loss per share $0.39

Aug 8 (Reuters) - Nektar Therapeutics

* Nektar therapeutics reports financial results for the second quarter of 2017

* Q2 loss per share $0.39

* Q2 revenue $34.6 million versus i/b/e/s view $34.2 million

* Q2 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below